🇺🇸 FDA
Pipeline program

Dopacis 90 MBq/ml oplossing voor injectie

ICO-202-28 DOPACER

Phase 2 small_molecule active

Quick answer

Dopacis 90 MBq/ml oplossing voor injectie for patients with newly discovered brain metastases (non-small cell lung cancer, breast cancer or melanoma) measuring more than 5 mm and explored on MRI is a Phase 2 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
CERO THERAPEUTICS HOLDINGS, INC.
Indication
patients with newly discovered brain metastases (non-small cell lung cancer, breast cancer or melanoma) measuring more than 5 mm and explored on MRI
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials